MedTrace Logo

Lake Washington Vascular VenaSeal™ Post-Market Evaluation

NCT04146168 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2019-10-31

No results posted yet for this study

Summary

New-WAVES Study seeks to expand understanding/results from prior study (NCT02585726). Assessing both clinical outcomes and patient satisfaction after treatment with Venaseal/Cyanoacrylate Adhesive Closure System

Conditions

  • Varicose Veins
  • Venous Reflux

Interventions

DIAGNOSTIC_TEST

Ultrasound

Closure of previously treated veins (with Venaseal) will be assessed via ultrasound.

Sponsors & Collaborators

  • Medtronic Vascular

    collaborator INDUSTRY

  • Lake Washington Vascular

    lead OTHER

Principal Investigators

  • Kathleen Gibson, MD · Lake Washington Vascular, PLLC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2020-01-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04146168 on ClinicalTrials.gov